Turning Personal Experience into Better Patient Outcomes

September 08, 2020

Luke Forster-Broten, Director of Product Innovation at Surescripts, sat down with me to talk about the importance of having the prescription cost conversation at the point of care—and how that idea helped inspire the development of our Electronic Prior Authorization solution.

"[There’s] a lot of burden on the patient to be their own best advocate, at a time when it's really hard to be an advocate for yourself,” said Luke. “If a prescription requires prior authorization, that could be the difference between staying and getting it at the pharmacy or leaving the pharmacy and never going back.”

Luke shares his own experience as a patient—including the lack of conversation with his own provider and subsequent price shock at the pharmacy—and offers additional insight into how price transparency and prior authorization at the point of care translate to better patient outcomes.

Related Articles

August 25, 2020

Three Ways Health Plans Can Address Inefficiencies and Medication Adherence

It is well known that Americans are grappling with rising health care costs and that all sectors of the health care industry have a role to play in addressing this issue. Read more...
August 13, 2020

Prior Authorization: On the Path to Quality, Affordability and Safety

In a recent survey by America’s Health Insurance Plans (AHIP), health insurance providers pointed to the automation of the prescription prior authorization process as a critical area in need of meaningful reform. Specifically, 84% of health plans identified automating the prior authorization process as one of the biggest opportunities for improvement. Read more...
August 03, 2020

CMS Price Transparency Rule is Fast Approaching

In 2019, the Centers for Medicare & Medicaid Services (CMS) issued its Medicare Advantage and Part D Drug Pricing Final Rule requiring Medicare Part D health plans integrate a real time benefit tool with at least one prescriber’s ePrescribing system or EHR, no later than January 1, 2021. CMS also mandated that all Part D plans send to patients an explanation of benefits that incorporates price transparency and less expensive alternatives once a month. Read more...